Idorsia Ltd (IDRSF)
OTCMKTS · Delayed Price · Currency is USD
3.500
-0.090 (-2.51%)
At close: Aug 7, 2025
Idorsia Market Cap
Idorsia has a market cap or net worth of $685.66 million as of August 22, 2025. Its market cap has increased by 46.66% in one year.
Market Cap
685.66M
Enterprise Value
2.21B
Revenue
273.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.50
Market Cap Chart
Since June 16, 2017, Idorsia's market cap has decreased from 1.67B to 685.66M, a decrease of -58.96%. That is a compound annual growth rate of -10.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 685.66M | 301.73% |
| Dec 30, 2024 | 170.68M | -61.86% |
| Dec 29, 2023 | 447.53M | -82.63% |
| Dec 30, 2022 | 2.58B | -28.59% |
| Dec 30, 2021 | 3.61B | -24.95% |
| Dec 30, 2020 | 4.81B | 18.47% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Glass House Brands | 632.06M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 368.43M |